Medical treatment of uveal melanoma.
Dipartimento di Oncologia Medica A, Istituto Nazionale per la Ricerca sul Cancro, Genova.
Paola
P
Queirolo
Mirko
M
Acquati
D000328:Adult; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000069461:Bendamustine Hydrochloride; D002066:Busulfan / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D003131:Combined Modality Therapy; D003606:Dacarbazine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000493:pharmacokinetics / Q000627:therapeutic use; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D004621:Embolization, Therapeutic; D015353:Eye Enucleation; D006801:Humans; D006979:Hyperthermia, Induced / Q000379:methods; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary / Q000628:therapy; D008545:Melanoma / Q000188:drug therapy* / Q000235:genetics / Q000556:secondary / Q000601:surgery / Q000628:therapy; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D009607:Nitrosourea Compounds / Q000493:pharmacokinetics / Q000627:therapeutic use; D009943:Organophosphorus Compounds / Q000493:pharmacokinetics / Q000627:therapeutic use; D011379:Prognosis; D012189:Retrospective Studies; D000077204:Temozolomide; D014604:Uveal Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000601:surgery; D000093542:Gemcitabine
D018906:Antineoplastic Agents, Alkylating; D009588:Nitrogen Mustard Compounds; D009607:Nitrosourea Compounds; D009943:Organophosphorus Compounds; D003841:Deoxycytidine; D003606:Dacarbazine; D000069461:Bendamustine Hydrochloride; C018404:treosulfan; D002066:Busulfan; C054368:fotemustine; D000077204:Temozolomide; D000093542:Gemcitabine